De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
ELV Overzicht aandelen
Elevance Health, Inc. is, samen met haar dochterondernemingen, actief als ziektekostenverzekeraar in de Verenigde Staten.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 6/6 |
| Toekomstige groei | 1/6 |
| Prestaties in het verleden | 3/6 |
| Financiële gezondheid | 4/6 |
| Dividenden | 3/6 |
Beloningen
Risicoanalyse
ELV onze risicocontroles hebben doorstaan.
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
Strategic Initiatives And Analytical Optimism Signal Bright Future In Healthcare Sector
Elevance Health, Inc. Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | US$492.07 |
| 52 Week Hoogtepunt | US$567.26 |
| 52 Week Laag | US$435.99 |
| Bèta | 0.83 |
| 11 maand verandering | -9.20% |
| 3 maanden verandering | -6.55% |
| 1 Jaar Verandering | 9.36% |
| 33 jaar verandering | 27.42% |
| 5 jaar verandering | 107.14% |
| Verandering sinds IPO | 2,306.21% |
Recent nieuws en updates
Investors Continue Waiting On Sidelines For Elevance Health, Inc. (NYSE:ELV)
Sep 11
Elevance Health: Strong Earnings Growth Supports Strong Dividend Growth
Sep 06There's Been No Shortage Of Growth Recently For Elevance Health's (NYSE:ELV) Returns On Capital
Aug 29Here's Why We Think Elevance Health (NYSE:ELV) Is Well Worth Watching
Aug 02Recent updates
Investors Continue Waiting On Sidelines For Elevance Health, Inc. (NYSE:ELV)
Sep 11Elevance Health: Strong Earnings Growth Supports Strong Dividend Growth
Sep 06There's Been No Shortage Of Growth Recently For Elevance Health's (NYSE:ELV) Returns On Capital
Aug 29Here's Why We Think Elevance Health (NYSE:ELV) Is Well Worth Watching
Aug 02Elevance Health: Healthcare Services Segment Is Gaining Traction
Jul 31Elevance Health: Buy A Dividend Growth Machine
Jul 18Elevance Health: Favorable Trends Are Emerging (Rating Upgrade)
Jun 28Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?
Jun 11Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher
May 27We Think Shareholders Will Probably Be Generous With Elevance Health, Inc.'s (NYSE:ELV) CEO Compensation
May 09Elevance Health (NYSE:ELV) Has Announced A Dividend Of $1.63
Apr 25Elevance Health: It's Not Too Late To Buy Their Dividend Growth
Apr 23Is Elevance Health (NYSE:ELV) Using Too Much Debt?
Apr 16Elevance Health: Not Doing Enough In 2024 To Justify Premium Price
Apr 11Elevance Health, Inc.'s (NYSE:ELV) Earnings Haven't Escaped The Attention Of Investors
Apr 01Elevance: A Healthy Dose Of Dividend Growth
Mar 21Elevance Heath: Financial Growth And Technical Strength Indicate A Buy
Mar 07Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.63
Feb 19Elevance Health: Time To Buy This Incredible Dividend Growth Stock
Jan 26Slowing Rates Of Return At Elevance Health (NYSE:ELV) Leave Little Room For Excitement
Jan 19Is Elevance Health (NYSE:ELV) A Risky Investment?
Jan 02Elevance Health, Inc.'s (NYSE:ELV) Shares Not Telling The Full Story
Dec 18A Look At Elevance's Margin Dynamics
Nov 23Is It Time To Consider Buying Elevance Health, Inc. (NYSE:ELV)?
Nov 16Elevance Health: A High Conviction Defensive Blue Chip Buy
Oct 19These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Safely
Oct 04Elevance: Pave The Way For The Next UnitedHealth
Sep 21Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital
Sep 18Here's The Price I Would Buy Elevance Health Stock
Sep 13If EPS Growth Is Important To You, Elevance Health (NYSE:ELV) Presents An Opportunity
Aug 18Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?
Aug 04Narrowing Down High-Quality Dividend Growth: Elevance Health Is Elemental
Jul 24Elevance Health: Beaten Down Share Price Offers Solid Potential
Jul 10Here's Why Elevance Health (NYSE:ELV) Can Manage Its Debt Responsibly
Jul 05Elevance Health: A Critical Update (Rating Downgrade)
Jun 05Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher
Jun 04Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?
May 05We Think Elevance Health (NYSE:ELV) Can Stay On Top Of Its Debt
Apr 04Elevance Health's (NYSE:ELV) Dividend Will Be Increased To $1.48
Feb 17Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital
Feb 13Elevance Health: Attractive On Its Expansion Catalysts
Feb 09Elevance Health (NYSE:ELV) Has Announced That It Will Be Increasing Its Dividend To $1.48
Jan 28Elevance Health acquiring Blue Cross and Blue Shield of Louisiana
Jan 23Elevance Health Offers Great Value
Jan 17At US$483, Is Elevance Health Inc. (NYSE:ELV) Worth Looking At Closely?
Jan 17Elevance Health: Strong And Steady EPS Growth Ahead, High Relative Strength Name
Jan 02Elevance Health (NYSE:ELV) Seems To Use Debt Rather Sparingly
Nov 28Rendement voor aandeelhouders
| ELV | US Healthcare | US Markt | |
|---|---|---|---|
| 7D | -6.1% | -1.2% | 0.4% |
| 1Y | 9.4% | 8.2% | 32.6% |
Rendement versus industrie: ELV overtrof de US Healthcare industrie, die het afgelopen jaar een rendement 8.2 % opleverde.
Rendement versus markt: ELV presteerde slechter dan US Market, dat het afgelopen jaar een rendement van 33.4 % opleverde.
Prijsvolatiliteit
| ELV volatility | |
|---|---|
| ELV Average Weekly Movement | 3.1% |
| Healthcare Industry Average Movement | 7.2% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 15.0% |
| 10% least volatile stocks in US Market | 3.1% |
Stabiele aandelenkoers: ELV heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 3% ) van ELV is het afgelopen jaar stabiel geweest.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 2001 | 104,900 | Gail Boudreaux | www.elevancehealth.com |
Elevance Health, Inc. is, samen met haar dochterondernemingen, actief als ziektekostenverzekeraar in de Verenigde Staten. Het bedrijf is actief in vier segmenten: Health Benefits, CarelonRx, Carelon Services en Corporate & Other. Het biedt een verscheidenheid aan gezondheidsplannen en -diensten aan leden van het programma; gezondheidsproducten; een reeks op vergoedingen gebaseerde administratieve beheerde zorgdiensten; en gespecialiseerde en andere verzekeringsproducten en -diensten, zoals stop loss, tandheelkunde, gezichtsvermogen, leven, invaliditeit en aanvullende ziektekostenverzekeringen.
Elevance Health, Inc. Samenvatting
| ELV fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | US$114.10b |
| Inkomsten(TTM) | US$6.69b |
| Inkomsten(TTM) | US$171.72b |
17.1x
Koers/Winstverhouding0.7x
P/S-verhoudingIs ELV overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| ELV resultatenrekening (TTM) | |
|---|---|
| Inkomsten | US$171.72b |
| Kosten van inkomsten | US$123.06b |
| Brutowinst | US$48.66b |
| Overige uitgaven | US$41.97b |
| Inkomsten | US$6.69b |
Laatst gerapporteerde inkomsten
Jun 30, 2024
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | 28.85 |
| Brutomarge | 28.34% |
| Nettowinstmarge | 3.90% |
| Schuld/Eigen Vermogen Verhouding | 71.8% |
Hoe presteerde ELV op de lange termijn?
Bekijk historische prestaties en vergelijking